Sinclair Carr was investigating a paradox that had puzzled health researchers for years: why did some studies suggest a glass of red wine might protect the heart, while others insisted even modest drinking carried real danger? As a doctoral candidate in epidemiology at the Harvard T.H. Chan School of Public Health, Carr teamed up with senior author Jürgen Rehm of the Institute for Mental Health Policy Research at the Center for Addiction and Mental Health to conduct a sweeping review that would, at last, attempt to settle the debate.
The answer, it turns out, lies in the limitations of older research methods. Conventional observational studies—observing large populations over time—had long suggested that moderate drinkers enjoyed lower rates of heart disease. But newer Mendelian randomization studies, which use genetic data to sidestep some of the biases inherent in asking people about their habits, largely failed to replicate those findings. "Many Mendelian randomization studies found no association between alcohol consumption and risk of these diseases," Carr explained. The "French paradox"—the notion that red wine explained why certain European populations seemed protected from heart disease—may have been an artifact of confounding factors. Perhaps it wasn't the alcohol improving health outcomes, but rather being somewhat wealthier or eating a healthier diet.
The review, which drew on global data feeding into the World Health Organization's Global Status Report on Alcohol and Health, confirmed that more than sixty diseases are entirely attributable to alcohol consumption, spanning everything from liver cirrhosis to certain cancers. Yet the researchers emphasized a finding that offers genuine hope: much of the damage caused by drinking can be slowed or even reversed once someone cuts back or quits entirely.
The nuance, however, resists simple prescription. "We cannot say that there is risk-free drinking, but we also cannot say that low amounts are clearly harmful," said Rehm. For breast cancer—the most extensively studied alcohol-related malignancy—consuming one glass of wine every other day does incrementally raise risk, while simultaneously offering some protective effect against heart disease. The increased risk of one disease might be canceled out by the reduced risk of another. The researchers stress they are painting a picture for populations; individuals carry vastly more personal information, from family medical histories to lifestyle factors.
The hope embedded in this work is not just scientific reconciliation—though that matters. It's the reminder embedded in the findings themselves: that bodies can heal, that decisions made today carry weight, and that understanding risk more clearly is itself a form of empowerment.